
09 Nov 2017 Governance
Leukaemia UK is the new name for the ‘Elimination of Leukaemia Fund’
Since November 2017 Leukaemia UK is the new name for the Elimination of Leukaemia Fund.
For the last four decades, Leukaemia UK has been making a difference to those living with blood cancer. We fund emotional support, pay for new hospital facilities, offer critical financial help and fund innovative research into better care and treatments for blood cancers.
We have used this, our 40th year, to review our work and achievements to develop a new strategy and vision for the future.
We want to increase our impact by supporting more families affected by blood cancer and by working with more hospitals around the UK.
Now feels like a good time to change our name from the Elimination of Leukaemia Fund to Leukaemia UK to reflect this ambition. We still hold tight to the founding principles of this charity which are:
- to improve care and support for people living with blood cancer
- to fund innovative research to find kinder, more effective ways of treating blood cancer
We have been fortunate to benefit from free consultancy from Frontera, a creative digital agency. The company has helped us develop a new name, logo and brand, at no cost to our supporters.
This new name encompasses our work as a leading blood cancer charity working for a blood cancer cure and improved care. Our work will remain the same, covering all blood cancers and related disorders.
Our name change won’t affect our charity registration number, office address, bank details and company numbers. For those who donate to us through payroll giving, standing order or direct debit, you won’t need to change anything.
We remain completely reliant on voluntary donations to keep our charity and its important work running. Thank you for your generous support and for being part of our exciting journey.
Find out more about:
- Our projects
- Our History
- Our work with King’s College Hospital in London
- Supporting you
- Ways to support us
Related posts
16 November 2021
Charities call on NHS to treat blood cancer equally in decision-making
The Blood Cancer Alliance undertook an evidence review to inform a new report exploring the unmet needs of people with blood cancer across the UK.
15 June 2018
Nick Boles’ Ambulatory Care Unit opening speech
An edited extract of the speech Nick Boles MP made at the official opening of the Leukaemia UK Ambulatory Care Unit.
29 July 2026
Research Blog: A new target for paediatric AML
In May this year one of our Leukaemia UK funded John Goldman Fellows, Dr Noelia Che, published a new paper along with her colleagues: MCL1 inhibition to enhance the efficacy…
23 October 2024
Leukaemia UK announces innovative projects by four female researchers addressing aggressive blood cancers
Leukaemia UK has today announced it will invest £600,000 into four groundbreaking research projects aimed at developing kinder, more effective treatments for various aggressive blood cancers, including acute myeloid leukaemia…